I'm not that impressed by the financials revealed in the new 8-K. However, I did not do any fondamental analysis cuz I know nothing in the biomedical field. Any opinion on this?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.